Ahmet Uluer

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation

Frank J. Accurso, Steven M. Rowe, John P. Clancy et al. · New England Journal of Medicine · 2010 · 802 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

Jane C. Davies, Samuel M. Moskowitz, Cynthia D. Brown et al. · New England Journal of Medicine · 2018 · 326 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +13

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.

Bryan L. Roth, S Craigo, M S Choudhary et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 211 citations

Medicine, Pharmacology, Psychiatry +12

Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation

Daniel Gelfond, Sonya L. Heltshe, Chang‐Xing Ma et al. · Clinical and Translational Gastroenterology · 2017 · 150 citations · Full text

Medicine, Pharmacology, Physiology +17

Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.

M S Choudhary, Nancy A. Sachs, Ahmet Uluer et al. · Molecular Pharmacology · 1995 · 91 citations

Medicine, Molecular Biology, Pharmacology +14